Item Type | Name |
Concept
|
Melanoma
|
Concept
|
Melanoma, Experimental
|
Academic Article
|
Systematic identification of signaling pathways with potential to confer anticancer drug resistance.
|
Academic Article
|
Molecular platforms utilized to detect BRAF V600E mutation in melanoma.
|
Academic Article
|
Pigmented extramammary Paget disease of the thigh mimicking a melanocytic tumor: report of a case and review of the literature.
|
Academic Article
|
Loss of microRNA-205 expression is associated with melanoma progression.
|
Academic Article
|
Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
|
Academic Article
|
Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses.
|
Academic Article
|
Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.
|
Academic Article
|
Angiomatoid Spitz nevus: a clinicopathological study of six cases and a review of the literature.
|
Academic Article
|
Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor.
|
Academic Article
|
miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
|
Academic Article
|
Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma.
|
Academic Article
|
Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature.
|
Academic Article
|
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target.
|
Academic Article
|
Cutaneous Eyelid Neoplasms as a Toxicity of Vemurafenib Therapy.
|
Academic Article
|
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
|
Academic Article
|
Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.
|
Academic Article
|
Emerging clinical applications of selected biomarkers in melanoma.
|
Academic Article
|
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.
|
Academic Article
|
Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma.
|
Academic Article
|
miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
|
Academic Article
|
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.
|
Academic Article
|
Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.
|
Academic Article
|
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
|
Academic Article
|
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
|
Academic Article
|
Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.
|
Academic Article
|
Clinicopathological features and clinical outcomes associated with TP53 and BRAFN on- V 600 mutations in cutaneous melanoma patients
|
Academic Article
|
SFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
|
Academic Article
|
Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma
|
Academic Article
|
High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients
|
Academic Article
|
Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions
|
Academic Article
|
Emerging clinical applications of selected biomarkers in melanoma
|
Academic Article
|
miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
|
Academic Article
|
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma
|
Academic Article
|
Resistant mechanisms to BRAF inhibitor PLX4032 in melanoma
|
Academic Article
|
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
|
Academic Article
|
Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas
|
Academic Article
|
Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma.
|
Academic Article
|
Epithelial, non-melanocytic and melanocytic proliferations of the ocular surface.
|
Academic Article
|
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.
|
Academic Article
|
Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
|
Academic Article
|
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
|
Academic Article
|
Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
|
Academic Article
|
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma.
|
Academic Article
|
Histopathologic and mutational analysis of a case of blue nevus-like melanoma.
|
Academic Article
|
Living on the Edge: Diagnosing Sarcomatoid Melanoma Using Histopathologic Cues at the Edge of a Dedifferentiated Tumor: A Report of 2 Cases and Review of the Literature.
|
Academic Article
|
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.
|
Academic Article
|
Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas.
|
Academic Article
|
Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions.
|
Academic Article
|
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
|
Academic Article
|
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.
|
Academic Article
|
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade.
|
Academic Article
|
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
|
Academic Article
|
Primary orbital melanoma in association with cellular blue nevus.
|
Academic Article
|
Significance of epidermal mitoses in challenging melanocytic proliferations.
|
Academic Article
|
High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients.
|
Academic Article
|
Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall.
|
Academic Article
|
Aberrant expression of FLI-1 in melanoma.
|
Academic Article
|
Intraepithelial Melanoma in the Stomach After Treatment With Immune Checkpoint Blockade Therapy.
|
Academic Article
|
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.
|
Academic Article
|
Toward a Molecular-Genetic Classification of Spitzoid Neoplasms.
|
Academic Article
|
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.
|
Academic Article
|
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
|
Academic Article
|
Desmoplastic Melanoma of the Periorbital Region.
|
Academic Article
|
Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma.
|
Academic Article
|
Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfall.
|
Academic Article
|
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
|
Academic Article
|
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
|
Academic Article
|
Summary of expression of SPARC protein in cutaneous vascular neoplasms and mimickers.
|
Academic Article
|
Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.
|
Academic Article
|
Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade.
|
Academic Article
|
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern.
|
Academic Article
|
Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall.
|
Academic Article
|
Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility.
|
Academic Article
|
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions.
|
Academic Article
|
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.
|
Academic Article
|
Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow-Resident Melanoma CTCs.
|
Academic Article
|
Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma.
|
Academic Article
|
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
Academic Article
|
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
Academic Article
|
Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
Academic Article
|
Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
|
Academic Article
|
Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.
|
Academic Article
|
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
|
Academic Article
|
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
|
Academic Article
|
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy.
|
Academic Article
|
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas.
|
Concept
|
Melanoma-Specific Antigens
|
Concept
|
gp100 Melanoma Antigen
|
Academic Article
|
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
|
Academic Article
|
Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literature.
|
Academic Article
|
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features.
|
Academic Article
|
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma.
|
Academic Article
|
Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.
|
Academic Article
|
Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma.
|
Academic Article
|
Unusual cutaneous metastatic carcinoma.
|
Academic Article
|
Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity.
|
Academic Article
|
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma.
|
Academic Article
|
B cells and tertiary lymphoid structures promote immunotherapy response.
|
Academic Article
|
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
|
Academic Article
|
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma.
|
Academic Article
|
BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma.
|
Academic Article
|
TERT amplification but not activation of canonical Wnt/?-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
|
Academic Article
|
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
|
Academic Article
|
Without Missing a Beat: Absence of Cilia Informs the Diagnosis of Histopathologically Challenging Spitzoid Melanocytic Neoplasms.
|
Academic Article
|
Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma.
|
Academic Article
|
Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive review.
|
Academic Article
|
Prognostic significance of acral lentiginous histologic type in T1 melanoma.
|
Academic Article
|
Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma.
|
Academic Article
|
Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report.
|
Academic Article
|
Clinical validity of a gene expression signature in diagnostically uncertain neoplasms.
|
Academic Article
|
A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma.
|
Academic Article
|
Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma.
|
Academic Article
|
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker.
|
Academic Article
|
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
|
Academic Article
|
Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration-Melanoma Research Alliance Public Workshop.
|
Academic Article
|
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.
|
Academic Article
|
Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases.
|
Academic Article
|
Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management.
|
Academic Article
|
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
|
Academic Article
|
iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation.
|
Academic Article
|
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.
|
Academic Article
|
High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens.
|
Academic Article
|
Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1.
|
Academic Article
|
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
|
Academic Article
|
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma.
|
Academic Article
|
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
|
Academic Article
|
Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors.
|
Academic Article
|
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
|
Academic Article
|
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
|
Academic Article
|
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.
|
Academic Article
|
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
|
Academic Article
|
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.
|
Academic Article
|
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.
|
Academic Article
|
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
|
Academic Article
|
Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations.
|
Academic Article
|
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.
|